<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK6803" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK6803/" /><meta name="ncbi_pagename" content="SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/05/18" /><meta name="citation_author" content="Ayman W El-Hattab" /><meta name="citation_author" content="Fernando Scaglia" /><meta name="citation_pmid" content="20301762" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK6803/" /><meta name="citation_keywords" content="SUCLA2 Deficiency" /><meta name="citation_keywords" content="SUCLA2 Deficiency" /><meta name="citation_keywords" content="Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial" /><meta name="citation_keywords" content="SUCLA2" /><meta name="citation_keywords" content="SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ayman W El-Hattab" /><meta name="DC.Contributor" content="Fernando Scaglia" /><meta name="DC.Date" content="2017/05/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK6803/" /><meta name="description" content="SUCLA2-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized by onset of the following features in infancy or childhood (median age of onset 2 months; range of onset birth to 6 years): psychomotor retardation, hypotonia, dystonia, muscular atrophy, sensorineural hearing impairment, postnatal growth retardation, and feeding difficulties. Other, less frequent, features include distinctive facial features, contractures, kyphoscoliosis, gastroesophageal reflux, ptosis, choreoathetosis, ophthalmoplegia, and epilepsy (infantile spasms or generalized convulsions). The median survival is 20 years; approximately 30% of affected individuals succumb during childhood. Affected individuals may have hyperintensities in the basal ganglia, cerebral atrophy, and leukoencephalopathy on head MRI. Elevation of methylmalonic acid (MMA) in the urine and plasma is found in a vast majority of affected individuals, although at levels that are far below those typically seen in individuals with classic methylmalonic aciduria." /><meta name="og:title" content="SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria" /><meta name="og:type" content="book" /><meta name="og:description" content="SUCLA2-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized by onset of the following features in infancy or childhood (median age of onset 2 months; range of onset birth to 6 years): psychomotor retardation, hypotonia, dystonia, muscular atrophy, sensorineural hearing impairment, postnatal growth retardation, and feeding difficulties. Other, less frequent, features include distinctive facial features, contractures, kyphoscoliosis, gastroesophageal reflux, ptosis, choreoathetosis, ophthalmoplegia, and epilepsy (infantile spasms or generalized convulsions). The median survival is 20 years; approximately 30% of affected individuals succumb during childhood. Affected individuals may have hyperintensities in the basal ganglia, cerebral atrophy, and leukoencephalopathy on head MRI. Elevation of methylmalonic acid (MMA) in the urine and plasma is found in a vast majority of affected individuals, although at levels that are far below those typically seen in individuals with classic methylmalonic aciduria." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK6803/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sucla2-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK6803/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CE97BE042AA8100000000001A000A.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK6803_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK6803_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/stxbp1-ee/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/suclg1-mtddepl/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK6803_"><span class="title" itemprop="name"><i>SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: SUCLA2 Deficiency</div><p class="contrib-group"><span itemprop="author">Ayman W El-Hattab</span>, MD, FAAP, FACMG and <span itemprop="author">Fernando Scaglia</span>, MD, FAAP, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK6803_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK6803_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ayman W El-Hattab</span>, MD, FAAP, FACMG<div class="affiliation small">Associate Professor, Department of Clinical Sciences<br />College of Medicine<br />University of Sharjah<br />Sharjah, United Arab Emirates<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@wabattahle" class="oemail">moc.oohay@wabattahle</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Fernando Scaglia</span>, MD, FAAP, FACMG<div class="affiliation small">Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@ailgacsf" class="oemail">ude.mcb@ailgacsf</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 26, 2009</span>; Last Revision: <span itemprop="dateModified">May 18, 2017</span>.</p><p><em>Estimated reading time: 13 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sucla2-def.Summary" itemprop="description"><h2 id="_sucla2-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SUCLA2</i>-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized by onset of the following features in infancy or childhood (median age of onset 2 months; range of onset birth to 6 years): psychomotor retardation, hypotonia, dystonia, muscular atrophy, sensorineural hearing impairment, postnatal growth retardation, and feeding difficulties. Other, less frequent, features include distinctive facial features, contractures, kyphoscoliosis, gastroesophageal reflux, ptosis, choreoathetosis, ophthalmoplegia, and epilepsy (infantile spasms or generalized convulsions). The median survival is 20 years; approximately 30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals succumb during childhood. Affected individuals may have hyperintensities in the basal ganglia, cerebral atrophy, and leukoencephalopathy on head MRI. Elevation of methylmalonic acid (MMA) in the urine and plasma is found in a vast majority of affected individuals, although at levels that are far below those typically seen in individuals with classic methylmalonic aciduria.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SUCLA2</i>-related mtDNA depletion syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SUCLA2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Physical therapy to maintain muscle function and prevent joint contractures; antiepileptic drugs for seizures; nasogastric or gastrostomy tube as needed to assure adequate caloric intake; chest physiotherapy, aggressive antibiotic treatment of chest infections, and respiratory aids such as assisted nasal ventilation or use of a tracheostomy and ventilator when indicated; bracing to treat scoliosis or kyphosis; blepharoplasty for significant ptosis; and hearing aids/cochlear implantation for sensorineural hearing loss.</p><p><i>Surveillance:</i> Routine monitoring of development, growth, and hearing; periodic ophthalmologic evaluations; routine skeletal evaluations for kyphoscoliosis and joint contractures.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SUCLA2</i>-related mtDNA depletion syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible once the pathogenic variants in the family have been identified.</p></div></div><div id="sucla2-def.Diagnosis"><h2 id="_sucla2-def_Diagnosis_">Diagnosis</h2><div id="sucla2-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>SUCLA2</i>-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria typically manifests during early infancy and <b>should be suspected</b> in individuals with a combination of the following clinical, brain MRI, and supportive laboratory and muscle biopsy findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Psychomotor retardation</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Sensorineural hearing impairment</div></li><li class="half_rhythm"><div>Dystonia</div></li><li class="half_rhythm"><div>Feeding difficulties</div></li><li class="half_rhythm"><div>Growth retardation / failure to thrive</div></li><li class="half_rhythm"><div>Muscular atrophy</div></li></ul><p><b>Brain MRI findings</b></p><ul><li class="half_rhythm"><div>Basal ganglia hyperintensities</div></li><li class="half_rhythm"><div>Cerebral atrophy</div></li><li class="half_rhythm"><div>Leukoencephalopathy</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div><b>Urine organic acid analysis</b></div><ul><li class="half_rhythm"><div>Elevation of methylmalonic acid (MMA) in the vast majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children. However, the MMA level is considerably less pronounced than in classic methylmalonic aciduria and can be only marginally elevated or even normal on rare occasions [<a class="bk_pop" href="#sucla2-def.REF.lamperti.2012.403">Lamperti et al 2012</a>].</div></li><li class="half_rhythm"><div>Several other metabolites may be elevated in urine, including methylcitrate, 3-methylglutaconic acid, 3-hydroxyisovaleric acid, and Krebs cycle intermediates such as succinate, fumarate, and 2-ketoglutarate [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Plasma MMA level</b></div><ul><li class="half_rhythm"><div>Elevation has been reported in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals analyzed, including those with marginally elevated urine MMA level [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</div></li><li class="half_rhythm"><div>Plasma MMA level may be more sensitive in identifying <i>SUCLA2</i>-related mtDNA depletion syndrome than urine organic acid analysis.</div></li></ul></li><li class="half_rhythm"><div><b>Acylcarnitine profile.</b> Elevated C3; thus, this condition can potentially be detected by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>.</div></li><li class="half_rhythm"><div><b>Plasma and CSF lactate levels.</b> Elevated in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li></ul><p><b>Muscle biopsy findings</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Increased fiber size variability, atrophic fibers, intracellular lipid accumulation, and COX-deficient fibers</div><div class="half_rhythm">Approximately 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals will have normal muscle histology [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">In some cases, structurally altered mitochondria with abnormal cristae on electron microscopy</div></li><li class="half_rhythm"><div class="half_rhythm">In the majority of individuals, abnormal electron transport chain activity</div><ul><li class="half_rhythm"><div>The most common abnormalities are combined complex I and IV deficiencies, combined complex I, III, and IV deficiencies, and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> complex IV deficiency.</div></li><li class="half_rhythm"><div>Electron transport chain activity has been reported to be normal in approximately 10% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who underwent this test [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Mitochondrial DNA content in muscle tissue of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals typically reduced to 20%-60% of tissue- and age-matched controls [<a class="bk_pop" href="#sucla2-def.REF.elpeleg.2005.1081">Elpeleg et al 2005</a>, <a class="bk_pop" href="#sucla2-def.REF.carrozzo.2007.862">Carrozzo et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.ostergaard.2007.853">Ostergaard et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>]</div></li></ul></div><div id="sucla2-def.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SUCLA2</i>-related mtDNA depletion syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SUCLA2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK6803/table/sucla2-def.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figsucla2defTmoleculargenetictestingu" rid-ob="figobsucla2defTmoleculargenetictestingu">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SUCLA2</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div><div class="half_rhythm">Note: Targeted analysis for the c.534+1G&#x0003e;A pathogenic <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> can be performed first in individuals of Faroese ancestry (see <a href="#sucla2-def.Prevalence">Prevalence</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SUCLA2</i> and other genes of interest (see <a href="#sucla2-def.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>SUCLA2</i>) fails to confirm a diagnosis in an individual with features of <i>SUCLA2</i>-related mtDNA depletion syndrome. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="sucla2-def.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6803/table/sucla2-def.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sucla2-def.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUCLA2</i></td><td headers="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">46/50&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_sucla2-def.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/50&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sucla2-def.TF.1.1"><p class="no_margin">See <a href="/books/NBK6803/#sucla2-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sucla2-def.TF.1.2"><p class="no_margin">See <a href="#sucla2-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="sucla2-def.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and splice-site variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="sucla2-def.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#sucla2-def.REF.matilainen.2015.325">Matilainen et al [2015]</a>, <a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al [2016]</a></p></div></dd><dt>5. </dt><dd><div id="sucla2-def.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="sucla2-def.Clinical_Characteristics"><h2 id="_sucla2-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sucla2-def.Clinical_Description"><h3>Clinical Description</h3><p>To date 50 individuals with <i>SUCLA2</i>-related mtDNA depletion syndrome have been reported [<a class="bk_pop" href="#sucla2-def.REF.elpeleg.2005.1081">Elpeleg et al 2005</a>, <a class="bk_pop" href="#sucla2-def.REF.carrozzo.2007.862">Carrozzo et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.ostergaard.2007.853">Ostergaard et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.morava.2009.438">Morava et al 2009</a>, <a class="bk_pop" href="#sucla2-def.REF.lamperti.2012.403">Lamperti et al 2012</a>, <a class="bk_pop" href="#sucla2-def.REF.navarrosastre.2012.409">Navarro-Sastre et al 2012</a>, <a class="bk_pop" href="#sucla2-def.REF.jaberi.2013.526">Jaberi et al 2013</a>, <a class="bk_pop" href="#sucla2-def.REF.matilainen.2015.325">Matilainen et al 2015</a>, <a class="bk_pop" href="#sucla2-def.REF.nogueira.2015.228">Nogueira et al 2015</a>, <a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>]. The clinical description here is based on what has been reported in these 50 individuals. The common clinical manifestations are summarized in <a class="figpopup" href="/books/NBK6803/table/sucla2-def.T.common_clinical_manifestati/?report=objectonly" target="object" rid-figpopup="figsucla2defTcommonclinicalmanifestati" rid-ob="figobsucla2defTcommonclinicalmanifestati">Table 2</a> [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</p><div id="sucla2-def.T.common_clinical_manifestati" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Common Clinical Manifestations of <i>SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6803/table/sucla2-def.T.common_clinical_manifestati/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sucla2-def.T.common_clinical_manifestati_lrgtbl__"><table><thead><tr><th id="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Frequency</th><th id="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Manifestations</th></tr></thead><tbody><tr><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;75%</td><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dystonia</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Psychomotor retardation</div></li><li class="half_rhythm"><div>Sensorineural hearing impairment</div></li></ul>
</td></tr><tr><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%-75%</td><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Feeding difficulties</div></li></ul>
</td></tr><tr><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">25%-50%</td><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Growth retardation / failure to thrive</div></li><li class="half_rhythm"><div>Muscular atrophy</div></li></ul>
</td></tr><tr><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;25%</td><td headers="hd_h_sucla2-def.T.common_clinical_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Choreoathetosis</div></li><li class="half_rhythm"><div>Distinctive facial features including brachycephaly, epicanthus, upslanted palpebral fissures</div></li><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Gastroesophageal reflux disease</div></li><li class="half_rhythm"><div>Hyperhidrosis</div></li><li class="half_rhythm"><div>Hypertonia</div></li><li class="half_rhythm"><div>Hypoglycemia</div></li><li class="half_rhythm"><div>Joint contractures</div></li><li class="half_rhythm"><div>Kyphoscoliosis</div></li><li class="half_rhythm"><div>Ophthalmoplegia</div></li><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Recurrent respiratory infections</div></li><li class="half_rhythm"><div>Recurrent vomiting</div></li><li class="half_rhythm"><div>Respiratory distress</div></li></ul>
</td></tr></tbody></table></div></div><p>Affected children with <i>SUCLA2</i>-related mtDNA depletion syndrome typically have an uncomplicated prenatal course and birth. Birth weight and birth length are typically within the normal range. The median age of onset of manifestations is two months, with a range from birth to six years [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</p><p><b>Neurocognitive.</b> The vast majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children present during infancy with hypotonia and psychomotor retardation. Dystonia and muscle atrophy also occur commonly. Other, less frequent, neurologic manifestations include hypertonia, choreoathetosis, ptosis, ophthalmoplegia, strabismus, and epilepsy (including infantile spasms and generalized convulsions). Brain MRI typically shows basal ganglia hyperintensities (70%), cerebral atrophy (70%), and leukoencephalopathy (15%) [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</p><p><b>Hearing.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children develop sensorineural hearing impairment; some benefit from a cochlear implant.</p><p><b>Growth.</b> Postnatal growth retardation with low weight and length/height is a common feature of this condition. Feeding difficulties, often necessitating tube feeding, occur commonly, while recurrent vomiting and gastroesophageal reflux disease occasionally occur. The feeding difficulties, recurrent vomiting, and gastroesophageal reflux disease can lead or contribute to failure to thrive in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants.</p><p><b>Distinctive facial features</b> including brachycephaly, epicanthus, and upslanted palpebral fissures, have been reported.</p><p><b>Respiratory.</b> Recurrent respiratory infections occur occasionally. Respiratory distress due to muscle weakness, obstructive sleep apnea, tracheomalacia, and abnormal breathing has also been reported.</p><p><b>Skeletal.</b> Progressive kyphoscoliosis has been reported occasionally and may require treatment. Joint contractures can develop in extremities secondary to decreased movement.</p><p><b>Other.</b> Hyperhidrosis and neonatal hypoglycemia have occasionally been reported. Other rare manifestations:</p><ul><li class="half_rhythm"><div>Anemia</div></li><li class="half_rhythm"><div>Acquired dislocation of hip and shoulder</div></li><li class="half_rhythm"><div>Irritability</div></li><li class="half_rhythm"><div>Sleep disturbance</div></li></ul><p><b>Life span</b> is shortened, with median survival of 20 years in individuals with <i>SUCLA2</i>-related mtDNA depletion syndrome. Approximately 30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reportedly died during childhood [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</p></div><div id="sucla2-def.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants can result in some residual enzyme activity, and hence a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Survival in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic missense variants was significantly longer than in those with biallelic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants (deletions, frameshift and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants) (median survival age 21 years vs 15 years) [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</p></div><div id="sucla2-def.Prevalence"><h3>Prevalence</h3><p><i>SUCLA2</i>-related mtDNA depletion syndrome is rare; the exact prevalence is unknown. To date, 50 individuals of different ethnic origins have been reported [<a class="bk_pop" href="#sucla2-def.REF.elpeleg.2005.1081">Elpeleg et al 2005</a>, <a class="bk_pop" href="#sucla2-def.REF.carrozzo.2007.862">Carrozzo et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.ostergaard.2007.853">Ostergaard et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.morava.2009.438">Morava et al 2009</a>, <a class="bk_pop" href="#sucla2-def.REF.lamperti.2012.403">Lamperti et al 2012</a>, <a class="bk_pop" href="#sucla2-def.REF.navarrosastre.2012.409">Navarro-Sastre et al 2012</a>, <a class="bk_pop" href="#sucla2-def.REF.jaberi.2013.526">Jaberi et al 2013</a>, <a class="bk_pop" href="#sucla2-def.REF.matilainen.2015.325">Matilainen et al 2015</a>, <a class="bk_pop" href="#sucla2-def.REF.nogueira.2015.228">Nogueira et al 2015</a>, <a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</p><p>A founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in families of Faroese origin has been identified (<a class="figpopup" href="/books/NBK6803/table/sucla2-def.T.selected_sucla2_pathogenic/?report=objectonly" target="object" rid-figpopup="figsucla2defTselectedsucla2pathogenic" rid-ob="figobsucla2defTselectedsucla2pathogenic">Table 4</a>); the disorder has a high incidence (1:1,700) and a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of 1:33 in the Faroe Islands [<a class="bk_pop" href="#sucla2-def.REF.ostergaard.2007.853">Ostergaard et al 2007</a>].</p></div></div><div id="sucla2-def.Genetically_Related_Allelic_D"><h2 id="_sucla2-def_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with pathogenic variants in <i>SUCLA2</i>.</p></div><div id="sucla2-def.Differential_Diagnosis"><h2 id="_sucla2-def_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>SUCLA2</i>-related mtDNA depletion syndrome needs to be differentiated from other mtDNA depletion syndromes, a genetically and clinically heterogeneous group of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders that are characterized by a severe reduction in mtDNA content leading to impaired energy production in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> tissues and organs.</p><p>Mitochondrial DNA depletion syndromes occur as a result of defects in mtDNA maintenance caused by pathogenic variants in nuclear genes that function in either mitochondrial nucleotide synthesis (e.g., <i>TK2</i>, <i>SUCLA2</i>, <i>SUCLG1</i>, <i>RRM2B</i>, <i>DGUOK</i>, and <i>TYMP</i>) or mtDNA replication (e.g., <i>POLG</i> and <i>TWNK</i>).</p><p>Mitochondrial DNA depletion syndromes are phenotypically classified into myopathic, encephalomyopathic, hepatocerebral, and neurogastrointestinal forms (<a class="figpopup" href="/books/NBK6803/table/sucla2-def.T.mitochondrial_dna_depletion/?report=objectonly" target="object" rid-figpopup="figsucla2defTmitochondrialdnadepletion" rid-ob="figobsucla2defTmitochondrialdnadepletion">Table 3</a>) [<a class="bk_pop" href="#sucla2-def.REF.elhattab.2013.186">El-Hattab &#x00026; Scaglia 2013</a>].</p><p><b>Myopathic forms</b> present in infancy or early childhood with hypotonia, proximal muscle weakness, and feeding difficulty. Cognition is usually spared. Typically, there is rapid progression of muscle weakness with respiratory failure and death within a few years of onset.</p><p><b>Encephalomyopathic mtDNA depletion syndromes</b> present in infancy with hypotonia and global developmental delay. Depending on the underlying defect, other features, including deafness, movement disorders, Leigh-like syndrome, and renal disease, can be observed.</p><p><b>Hepatocerebral forms</b> present with early-onset liver dysfunction and neurologic involvement, including developmental delay, abnormal eye movements, and peripheral neuropathy.</p><p><b>Neurogastrointestinal</b>
<b>forms,</b> the prototype of which is mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease, present in adolescence to early adulthood with progressive gastrointestinal dysmotility, cachexia, and peripheral neuropathy.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>SUCLG1</i>-related mtDNA depletion syndrome may be difficult to distinguish from <i>SUCLA2</i>-related mtDNA depletion. <i>SUCLG1</i>-related mtDNA depletion syndrome is characterized by psychomotor retardation, hypotonia, muscle atrophy, feeding difficulties, growth retardation, dystonia, hearing loss, lactic acidosis, elevated urine and plasma MMA, and mtDNA depletion. However, hepatopathy and cardiomyopathy occur in <i>SUCLG1</i>-related mtDNA depletion only [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2016.243">Carrozzo et al 2016</a>].</p><div id="sucla2-def.T.mitochondrial_dna_depletion" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Mitochondrial DNA Depletion Syndromes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6803/table/sucla2-def.T.mitochondrial_dna_depletion/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sucla2-def.T.mitochondrial_dna_depletion_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype&#x000a0;<sup>1</sup></th><th id="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial DNA Depletion Syndrome #, Type</th><th id="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Hepatocerebral</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DGUOK</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3, hepatocerebral type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dguok-mtddepl/">Deoxyguanosine Kinase Deficiency</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4A, Alpers type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>MPV17</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6<i>,</i> hepatocerebral type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mpv17-mtdep/"><i>MPV17</i>-Related Hepatocerebral Mitochondrial DNA Depletion Syndrome</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TWNK</i><br />(<i>C10orf2)</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7, hepatocerebral type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/271245" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">271245</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TFAM</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15, hepatocerebral type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/617156" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617156</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Encephalo-<br />myopathic</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUCLA2</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5, encephalomyopathic type w/methylmalonic aciduria</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FBXL4</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13, encephalomyopathic type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fbxl4-mtddepl/"><i>FBXL4</i>-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>SUCLG1</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9, encephalomyopathic type with methylmalonic aciduria</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/suclg1-mtddepl/"><i>SUCLG1</i>-Related mtDNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>RRM2B</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8A, encephalomyopathic type w/renal tubulopathy</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rrm2b-mtddepl/"><i>RRM2B</i>-Related Mitochondrial Disease</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>OPA1</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14, encephalocardiomyopathic type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/616896" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616896</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ABAT</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Encephalomyopathic type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/613163" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613163</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Neurogastro-<br />intestinal</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TYMP</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1, MNGIE type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mngie/">Mitochondrial Neurogastrointestinal Encephalopathy Disease</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4B, MNGIE type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>RRM2B</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8B, MNGIE type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rrm2b-mtddepl/"><i>RRM2B</i>-Related Mitochondrial Disease</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Myopathic</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TK2</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2, myopathic type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tk2-mtddepl/"><i>TK2</i>-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>AGK</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10, cardiomyopathic type (Sengers syndrome)</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/212350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">212350</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>MGME1</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11, myopathic type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/615084" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615084</a></td></tr><tr><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A4</i></td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12B, cardiomyopathic type</td><td headers="hd_h_sucla2-def.T.mitochondrial_dna_depletion_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/615418" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615418</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sucla2-def.TF.3.1"><p class="no_margin">Within each phenotypic category, mtDNA depletion syndromes are ordered by relative prevalence.</p></div></dd><dt>2. </dt><dd><div id="sucla2-def.TF.3.2"><p class="no_margin">See hyperlinked <i>GeneReview</i> or OMIM <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> entry for more information.</p></div></dd></dl></div></div></div></div><div id="sucla2-def.Management"><h2 id="_sucla2-def_Management_">Management</h2><div id="sucla2-def.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>SUCLA2</i>-related mtDNA depletion syndrome, the following evaluations need to be performed (if not already done as part of the initial diagnostic evaluation):</p><ul><li class="half_rhythm"><div>Comprehensive neurologic examination and developmental/cognitive assessment. The following diagnostic modalities can be used to assess the degree of neurologic involvement:</div><ul><li class="half_rhythm"><div>Neuroimaging (preferably brain MRI) to establish the degree of central nervous system involvement</div></li><li class="half_rhythm"><div>EMG to assess myopathy</div></li><li class="half_rhythm"><div>EEG if seizures are suspected</div></li></ul></li><li class="half_rhythm"><div>Audiologic evaluation</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>Nutritional evaluation and swallowing assessment for feeding difficulties and growth failure</div></li><li class="half_rhythm"><div>Physical examination for the back and joints for kyphoscoliosis and joint contractures</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sucla2-def.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management should involve a multidisciplinary team including specialists in neurology, audiology, child development, gastroenterology, nutrition, and clinical genetics. Treatments include the following:</p><ul><li class="half_rhythm"><div>Physical therapy to help maintain muscle function and prevent joint contractures</div></li><li class="half_rhythm"><div>Standard treatment with antiepileptic drugs for seizures</div></li><li class="half_rhythm"><div>Nutritional support by a dietitian and the use of a nasogastric tube or gastrostomy tube feedings to address feeding difficulties and failure to thrive</div></li><li class="half_rhythm"><div>Chest physiotherapy, aggressive antibiotic treatment of chest infections, and artificial ventilation (including assisted nasal ventilation or intubation and the use of a tracheostomy and ventilator) for respiratory insufficiency</div></li><li class="half_rhythm"><div>Bracing for scoliosis and kyphosis</div></li><li class="half_rhythm"><div>Blepharoplasty for significant ptosis</div></li><li class="half_rhythm"><div>Hearing aids and/or cochlear implantation for sensorineural hearing loss</div></li></ul></div><div id="sucla2-def.Surveillance"><h3>Surveillance</h3><p>No clinical guidelines for surveillance are available. The following evaluations are suggested, with frequency varying according to the severity of the condition:</p><ul><li class="half_rhythm"><div>Routine developmental and neurologic assessment</div></li><li class="half_rhythm"><div>Periodic nutritional and growth assessment</div></li><li class="half_rhythm"><div>Periodic hearing evaluation</div></li><li class="half_rhythm"><div>Periodic ophthalmologic examination</div></li><li class="half_rhythm"><div>Routine physical examination of back and joints for kyphoscoliosis and joint contractures</div></li></ul></div><div id="sucla2-def.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sucla2-def.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sucla2-def.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sucla2-def.Genetic_Counseling"><h2 id="_sucla2-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sucla2-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SUCLA2</i>-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="sucla2-def.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>SUCLA2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with <i>SUCLA2</i>-related mtDNA depletion syndrome are not reported to reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>SUCLA2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="sucla2-def.Carrier_Heterozygote_Detectio"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SUCLA2</i> pathogenic variants in the family.</p><p>In populations with a high <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> and/or a high rate of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a>, the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may be a carrier. Thus, the risk to offspring is most accurately determined after <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the proband's reproductive partner.</p></div><div id="sucla2-def.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sucla2-def.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SUCLA2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="sucla2-def.Resources"><h2 id="_sucla2-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="sucla2-def.Molecular_Genetics"><h2 id="_sucla2-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sucla2-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6803/table/sucla2-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sucla2-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sucla2-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sucla2-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sucla2-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sucla2-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sucla2-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sucla2-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sucla2-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8803" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SUCLA2</i></a></td><td headers="hd_b_sucla2-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8803" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">13q14<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_sucla2-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9P2R7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial</a></td><td headers="hd_b_sucla2-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SUCLA2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SUCLA2 database</a></td><td headers="hd_b_sucla2-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SUCLA2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SUCLA2</a></td><td headers="hd_b_sucla2-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SUCLA2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SUCLA2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sucla2-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sucla2-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria (<a href="/omim/603921,612073" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6803/table/sucla2-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sucla2-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603921" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603921</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SUCCINATE-CoA LIGASE, ADP-FORMING, BETA SUBUNIT; SUCLA2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612073" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612073</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5</td></tr></tbody></table></div></div><div id="sucla2-def.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>SUCLA2</i> and <i>SUCLG1</i> encode subunits of succinyl CoA ligase (SUCL). SUCL is a mitochondrial tricarboxylic acid cycle enzyme that catalyzes the reversible conversion of succinyl-CoA and ADP or GDP to succinate and ATP or GTP. SUCL is composed of an alpha subunit, encoded by <i>SUCLG1</i>, and a beta subunit, encoded by either <i>SUCLA2</i> or <i>SUCLG2</i>. The alpha subunit forms a heterodimer with either of its beta subunits, resulting in an ADP-forming SUCL and a GDP-forming SUCL, respectively. SUCL also forms a complex with the mitochondrial nucleoside diphosphate kinase, and the lack of this complex formation in SUCL deficiency has been suggested to disturb the kinase function, resulting in decreased mitochondrial nucleotide synthesis and therefore decreased mtDNA synthesis leading to mtDNA depletion [<a class="bk_pop" href="#sucla2-def.REF.kowluru.2002.160">Kowluru et al 2002</a>].</p><p><b>Gene structure.</b>
<i>SUCLA2</i> maps to 13q14.2, spans 58 kb, and contains 11 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK6803/#sucla2-def.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK6803/table/sucla2-def.T.selected_sucla2_pathogenic/?report=objectonly" target="object" rid-figpopup="figsucla2defTselectedsucla2pathogenic" rid-ob="figobsucla2defTselectedsucla2pathogenic">Table 4</a>.</p><div id="sucla2-def.T.selected_sucla2_pathogenic" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>SUCLA2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6803/table/sucla2-def.T.selected_sucla2_pathogenic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sucla2-def.T.selected_sucla2_pathogenic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sucla2-def.T.selected_sucla2_pathogenic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sucla2-def.T.selected_sucla2_pathogenic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sucla2-def.T.selected_sucla2_pathogenic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_sucla2-def.T.selected_sucla2_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.534+1G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_sucla2-def.T.selected_sucla2_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_sucla2-def.T.selected_sucla2_pathogenic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_003850.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003850<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_003841.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003841<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="sucla2-def.TF.4.1"><p class="no_margin">Founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the Faroe Islands [<a class="bk_pop" href="#sucla2-def.REF.carrozzo.2007.862">Carrozzo et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.ostergaard.2007.853">Ostergaard et al 2007</a>, <a class="bk_pop" href="#sucla2-def.REF.morava.2009.438">Morava et al 2009</a>]</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SUCLA2</i> encodes the 463 amino acids of the &#x003b2; subunit of the ADP-forming SUCL.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathogenic variants lead to dysfunctional SUCL protein. As SUCL forms a complex with the mitochondrial nucleoside diphosphate kinase, the lack of this complex formation in SUCL deficiency can disturb the kinase function, resulting in decreased mitochondrial nucleotide synthesis and therefore decreased mtDNA synthesis leading to mtDNA depletion [<a class="bk_pop" href="#sucla2-def.REF.kowluru.2002.160">Kowluru et al 2002</a>].</p></div></div><div id="sucla2-def.References"><h2 id="_sucla2-def_References_">References</h2><div id="sucla2-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.carrozzo.2007.862">Carrozzo R, Dionisi-Vici C, Steuerwald U, Lucioli S, Deodato F, Di Giandomenico S, Bertini E, Franke B, Kluijtmans LA, Meschini MC, Rizzo C, Piemonte F, Rodenburg R, Santer R, Santorelli FM, van Rooij A, Vermunt-de Koning D, Morava E, Wevers RA. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:862–74.</span> [<a href="/pubmed/17301081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17301081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.carrozzo.2016.243">Carrozzo R, Verrigni D, Rasmussen M, de Coo R, Amartino H, Bianchi M, Buhas D, Mesli S, Naess K, Born AP, Woldseth B, Prontera P, Batbayli M, Ravn K, Joensen F, Cordelli DM, Santorelli FM, Tulinius M, Darin N, Duno M, Jouvencel P, Burlina A, Stangoni G, Bertini E, Redonnet-Vernhet I, Wibrand F, Dionisi-Vici C, Uusimaa J, Vieira P, Osorio AN, McFarland R, Taylor RW, Holme E, Ostergaard E. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients. <span><span class="ref-journal">J Inherit Metab Dis. </span>2016;<span class="ref-vol">39</span>:243–52.</span> [<a href="/pubmed/26475597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26475597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.elhattab.2013.186">El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. <span><span class="ref-journal">Neurotherapeutics. </span>2013;<span class="ref-vol">10</span>:186–98.</span> [<a href="/pmc/articles/PMC3625391/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3625391</span></a>] [<a href="/pubmed/23385875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23385875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.elpeleg.2005.1081">Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, Rahman S, Pagnamenta A, Eshhar S, Saada A. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:1081–6.</span> [<a href="/pmc/articles/PMC1196446/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196446</span></a>] [<a href="/pubmed/15877282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15877282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.jaberi.2013.526">Jaberi E, Chitsazian F, Ali Shahidi G, Rohani M, Sina F, Safari I, Malakouti Nejad M, Houshmand M, Klotzle B, Elahi E. The novel mutation p.Asp251Asn in the &#x003b2;-subunit of succinate-CoA ligase causes encephalomyopathy and elevated succinylcarnitine. <span><span class="ref-journal">J Hum Genet. </span>2013;<span class="ref-vol">58</span>:526–30.</span> [<a href="/pubmed/23759946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23759946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.kowluru.2002.160">Kowluru A, Tannous M, Chen HQ. Localization and characterization of the mitochondrial isoform of the nucleoside diphosphate kinase in the pancreatic beta cell: evidence for its complexation with mitochondrial succinyl-CoA synthetase. <span><span class="ref-journal">Arch Biochem Biophys. </span>2002;<span class="ref-vol">398</span>:160–9.</span> [<a href="/pubmed/11831846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11831846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.lamperti.2012.403">Lamperti C, Fang M, Invernizzi F, Liu X, Wang H, Zhang Q, Carrara F, Moroni I, Zeviani M, Zhang J, Ghezzi D. A novel homozygous mutation in SUCLA2 gene identified by exome sequencing. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">107</span>:403–8.</span> [<a href="/pmc/articles/PMC3490101/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3490101</span></a>] [<a href="/pubmed/23010432" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23010432</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.matilainen.2015.325">Matilainen S, Isohanni P, Euro L, L&#x000f6;nnqvist T, Pihko H, Kivel&#x000e4; T, Knuutila S, Suomalainen A. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:325–30.</span> [<a href="/pmc/articles/PMC4326715/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4326715</span></a>] [<a href="/pubmed/24986829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24986829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.morava.2009.438">Morava E, Steuerwald U, Carrozzo R, Kluijtmans LA, Joensen F, Santer R, Dionisi-Vici C, Wevers RA. Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. <span><span class="ref-journal">Mitochondrion. </span>2009;<span class="ref-vol">9</span>:438–42.</span> [<a href="/pubmed/19666145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19666145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.navarrosastre.2012.409">Navarro-Sastre A, Tort F, Garcia-Villoria J, Pons MR, Nascimento A, Colomer J, Campistol J, Yoldi ME, L&#x000f3;pez-Gallardo E, Montoya J, Unceta M, Martinez MJ, Briones P, Ribes A. Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">107</span>:409–15.</span> [<a href="/pubmed/22980518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22980518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.nogueira.2015.228">Nogueira C, Meschini MC, Nesti C, Garcia P, Diogo L, Valongo C, Costa R, Videira A, Vilarinho L, Santorelli FM. A novel SUCLA2 mutation in a Portuguese child associated with &#x0201c;mild&#x0201d; methylmalonic aciduria. <span><span class="ref-journal">J Child Neurol. </span>2015;<span class="ref-vol">30</span>:228–32.</span> [<a href="/pubmed/24659738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24659738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sucla2-def.REF.ostergaard.2007.853">Ostergaard E, Hansen FJ, Sorensen N, Duno M, Vissing J, Larsen PL, Faeroe O, Thorgrimsson S, Wibrand F, Christensen E, Schwartz M. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:853–61.</span> [<a href="/pubmed/17287286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17287286</span></a>]</div></li></ul></div></div><div id="sucla2-def.Chapter_Notes"><h2 id="_sucla2-def_Chapter_Notes_">Chapter Notes</h2><div id="sucla2-def.Author_History"><h3>Author History</h3><p>Ayman W El-Hattab, MD, FAAP, FACMG (2016-present)<br />Elsebet Ostergaard, MD, PhD; National University Hospital Rigshospitalet (2009-2016)<br />Fernando Scaglia, MD, FAAP, FACMG (2016-present)</p></div><div id="sucla2-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>18 May 2017 (aa) Revision: <a href="#sucla2-def.Differential_Diagnosis">Differential Diagnosis</a> updated</div></li><li class="half_rhythm"><div>30 June 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 May 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>16 January 2009 (eo) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK6803</span><span class="label">PMID: <a href="/pubmed/20301762" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301762</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/stxbp1-ee/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/suclg1-mtddepl/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK6803&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK6803/?report=reader">PubReader</a></li><li><a href="/books/NBK6803/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK6803" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK6803" style="display:none" title="Cite this Page"><div class="bk_tt">El-Hattab AW, Scaglia F. SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria. 2009 May 26 [Updated 2017 May 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK6803/pdf/Bookshelf_NBK6803.pdf">PDF version of this page</a> (434K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sucla2-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sucla2-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sucla2-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sucla2-def.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sucla2-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sucla2-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sucla2-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sucla2-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sucla2-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sucla2-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sucla2-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8803[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SUCLA2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK6803+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1517972" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1517972" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1517972" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1517972" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28358460" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLG1</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLG1</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25582465" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [SUCLA2-related encephalomyopathic mitochondrial DNA depletion syndrome: a case report and review of literature].</a><span class="source">[Zhonghua Er Ke Za Zhi. 2014]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [SUCLA2-related encephalomyopathic mitochondrial DNA depletion syndrome: a case report and review of literature].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu Z, Fang F, Ding C, Wu H, Lyu J, Wu Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Zhonghua Er Ke Za Zhi. 2014 Nov; 52(11):817-21. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301409" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Methylmalonic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Methylmalonic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Manoli I, Sloan JL, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23230576" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TK2</i>-Related Mitochondrial DNA Maintenance Defect, Myopathic Form</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TK2</i>-Related Mitochondrial DNA Maintenance Defect, Myopathic Form<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang J, El-Hattab AW, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28383868" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FBXL4</i>-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FBXL4</i>-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Almannai M, Dai H, El-Hattab AW, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301762" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301762" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042ae639a66ee2babdb03c">SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form wit...</a><div class="ralinkpop offscreen_noflow">SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:37:10-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CE97BE042AA8100000000001A000A&amp;ncbi_session=CE8CE97BE042AE61_0026SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK6803%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK6803&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK6803/&amp;ncbi_pagename=SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CE97BE042AE61_0026SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>